Loudness dependence of auditory evoked potentials in obsessive-compulsive disorder: A pilot study

Psychiatry Research

Volumn 93, Issue 3, 2000, Pages 209-216

  Carrillo De La Peña, Maria T ^a   Mavrogiorgou, Paraskevi ^a   Juckel, Georg ^a   Hauke, Walter ^b   Gallinat, Jürgen ^a   Frodl, Thomas ^a   Zaudig, Michael ^b   Hegerl, Ulrich ^a  

^a Sect Clin Neurophysiol O   (Germany)

^b Psychosomatic Hospital   (Germany)

Author keywords

Augmenting reducing; Dipole source analysis; Electrophysiology; Serotonergic system

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EVOKED AUDITORY RESPONSE; FEMALE; HUMAN; HUMAN EXPERIMENT; LOUDNESS; MALE; NORMAL HUMAN; OBSESSION; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; TECHNIQUE;

ADULT; AUDITORY CORTEX; BRAIN MAPPING; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; LOUDNESS PERCEPTION; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; REFERENCE VALUES; SEROTONIN;

EID: 0034630245     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(00)00106-2     Document Type: Article

References (31)

1. American Electroencephalographic Society guidelines for standard electrode position nomenclature. Journal of Clinical Neurophysiology. 8:1991;200-202.
2. th edn. Author, Washington, DC.
3. Barr L.C., Goodman W.K., McDougle C.J., Delgado P.L., Heninger G.R., Charney D.S., Price L.H. Tryptophan depletion in patients with obsessive-compulsive disorder who respond to serotonin reuptake inhibitors. Archives of General Psychiatry. 51:1994;309-317.
4. Baumgarten H.G., Grozdanovic Z. Role of serotonin in obsessive-compulsive disorder. British Journal of Psychiatry. 173(suppl. 35):1998;13-20.
5. Bellodi L, Erzegovesi S., Bianchi L., Lucini V., Conca R., Lucca A. Plasma trytophan levels and tryptophan/neutral amino acid ratios in obsessive-compulsive patients with and without depression. Psychiatry Research. 69:1997;9-15.
6. Bruneau N., Barthélémy C., Roux S., Jouve J., Lelord G. Auditory evoked potential modifications according to clinical and biochemical responsiveness to fenfluramine treatment in children with autistic behavior. Neuropsychobiology. 21:1989;48-52.
7. Delgado P.L., Moreno F.A. Different roles for serotonin in anti-obsessional drug action and the pathophysiology of obsessive-compulsive disorder. British Journal of Psychiatry. 173(suppl. 35):1998;21-25.
8. Den Boer J.A. Psychopharmacology of comorbid obsessive-compulsive disorder and depression. Journal of Clinical Psychiatry. 58(suppl. 8):1997;17-19.
9. Fineberg N.A., Roberts A., Montgomery S.A., Cowen P.J. Brain 5-HT function in obsessive-compulsive disorder. Prolactin responses to D-fenfluramine. British Journal of Psychiatry. 171:1997;280-282.
10. Flament M.F., Rapoport J.L., Murphy D.L., Berg C.J., Lake C.R. Biochemical changes during clomipramine treatment of childhood obsessive-compulsive disorder. Archives of General Psychiatry. 44:1987;219-225.
11. Gallinat, J., Bottlender, R., Juckel, G., Munke-Puchner, A., Stotz, G., Kuß, H.J., Mavrogiourgou, P., Hegerl, U., 2000. Loudness dependence of the auditory evoked N1/P2-component as a predictor of acute SSRI response in depression. Psychopharmacology, in press.
12. Goodman W.K., McDougle C.J., Price L.H., Riddle M.A., Pauls D.L., Leckman J.F. Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive-compulsive disorder? Journal of Clinical Psychiatry. 51:1990;36-43.
13. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Fleischmann R., Hill C., Heninger G.R., Charney D.S. The Yale-Brown Obsessive Compulsive Scale (Y-BOCS). I. Development, use and reliability. Archives of General Psychiatry. 46:1989;1006-1011.
14. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Delgado P., Heninger G.R., Charney D.S. The Yale-Brown Obsessive Compulsive Scale (Y-BOCS). II. Validity. Archives of General Psychiatry. 46:1989;1012-1016.
15. Hamilton M. Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology. 6:1967;278-296.
16. Hegerl U., Bottlender R., Gallinat J., Kuss H., Ackenheil M., Möller H. The serotonin syndrome scale: first results on validity. European Archives of Psychiatry and Clinical Neuroscience. 248:1998;96-103.
17. Hegerl U., Gallinat J., Mrowinski D. Intensity dependence of auditory evoked dipole source activity. International Journal of Psychophysiology. 17:1998;1-13.
18. Hegerl U., Juckel G. Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis. Biological Psychiatry. 33:1993;173-187.
19. Hegerl U., Juckel G., Schmidt L.G., Rommelspacher H. Serotonergic ethanol effects and auditory evoked dipole activity in alcoholic and healthy subjects. Psychiatry Research. 63:1996;47-55.
20. 1A autoreceptors in the dorsal raphe nucleus. Neuropsychopharmacology 21.
21. Juckel G., Molnár M., Hegerl U., Csepe V., Karmos G. Auditory-evoked potentials as indicator of brain serotonergic activity - first evidence in behaving cats. Biological Psychiatry. 41:1997;1181-1195.
22. Leckman J.F., Goodman W.K., Anderson G.M., Riddle M.A., Chapell P.B., McSwiggan-Hardin M.T., McDougle C.J., Scahill L.D., Ort S.I., Pauls D.L., Cohen D.J., Price L.H. Cerebrospinal fluid biogenic amines in obsessive compulsive disorder, Tourette′s syndrome, and healthy controls. Neuropsychopharmacology. 12:1995;73-86.
23. Lesch K.P., Hoh A., Schulte H.M., Osterheider M., Müller T. Long-term fluoxetine treatment decreases 5-HT1a receptor responsivity in obsessive compulsive disorder. Psychopharmacology. 105:1991;415-420.
24. Montgomery S.A. Long-term management of obsessive-compulsive disorder. International Clinical Psychoparmacology. 11(suppl. 5):1996;23-29.
25. Murphy D.L. Peripheral indices of central serotonin function in human. Annals of the New York Academy of Sciences. 600:1990;282-296.
26. Paige S.R., Fitzpatrick D.F., Kline J.P., Balogh S., Hendricks S.E. Event-related potential amplitude/intensity slopes predict response to antidepressants. Neuropsychobiology. 30:1994;197-201.
27. Paige S.R., Hendricks S.E., Fitzpatrick D.F., Balogh S., Burke W.J. Amplitude/intensity functions of auditory event-related potentials predict responsiveness to bupropion in major depressive disorder. Psychopharmacology Bulletin. 31:1995;243-248.
28. Scherg M., Picton T.W. Separation and identification of event-related potential components by brain electric source analysis. Electroencephalography and Clinical Neurophysiology. 42:1991;24-37.
29. Scherg M., Von Cramon D. Dipole source potentials of the auditory cortex in normal subjects and on patients with temporal lobe lesions. Advances in Audiology. 6:1990;165-193.
30. Soubrié P. Reconciling the role of central serotonin neurons in human and animal behavior. Behavioral Brain Sciences. 9:1986;319-364.
31. Wang W., Timsit-Berthier M., Schoenen J. Intensity dependence of auditory evoked potentials is pronounced in migraine: an indication of cortical potentiation and low serotonergic neurotransmission? Neurology. 46:1996;1404-1409.